Drug Delivery Devices are used for administration of drug compounds in effective ways. Implantable ports, also called portacaths or subcutaneous ports, are used to administer chemotherapy, medicine, fluids, and nutrients, or take blood samples. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable ports devices market, including market shares of different players within Russia. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Russia Implantable Ports Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2023, GlobalData’s Market Model methodology determined that the leading player in the implantable ports market in Russia was CR Bard followed by AngioDynamics, B. Braun Melsungen, Teleflex, A.M.I. and Vygon.

An Implantable Port consists of a catheter with a small reservoir (port) attached to it. Implantable Ports covers both Double Lumen and Single Lumen Implantable Ports. A Double Lumen Port is a port with two access points. A Single Lumen Port is a port with one access point.

The value of the implantable ports devices market within Russia was expected to be over $4m in 2023.

For the latest complete market share analysis of implantable ports device market in Russia, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.